BioSpace News Archive

Global digital therapeutics innovator DarioHealth Corp., reported financial and operational results for the third quarter ended September 30, 2019.

PLx Pharma Inc. announced that the Company will release its 2019 third quarter financial results on Friday, November 8, 2019, before the U.S. financial markets open.

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that it will present results from seven studies at the 2019 National Society of Genetic Counselors annual meeting being held Nov. 5–8, 2019 in Salt Lake City.

Provides update from ongoing Phase 1/2 clinical trials of CTX001® for patients with severe hemoglobinopathies

Majority of physicians would be more likely to prescribe AXS-07 over current and other emerging treatments if AXS-07 efficacy is confirmed in ongoing MOMENTUM Phase 3 trial

The Ontario Lung Association report, Helping the Missing Million, aims to improve the diagnosis and treatment of COPD in Canada

15 presentations highlighting the transformational potential of LICA medicines for a broad range of rare and common diseases

Anixa Biosciences, Inc., a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, announced the appointment of Emanuele Ostuni, Ph.D. to its Scientific Advisory Board..

Company announces biotech entrepreneur Paul Morrill as Chief Business Officer and cell therapy veteran Florian Schuster as CFO/COO; company also named cell reprogramming pioneer Marius Wernig and immuno-oncologist Ramy Ibrahim to the scientific advisory board. [28-October-2019] CAMBRIDGE, United Kingdom , Oct. 28, 2019 /PRNewswire/ -- bit bio (formerly Elpis Biomed) t

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that the Company will release its third quarter 2019 financial results on Monday, November 11, 2019 before the U.S. financial markets open.